Aging isn’t a mystery. It can be understood and overcome.
We are the first and largest company dedicated to the research of longevity and aging in their totality. There are no fragmented solutions to a systemic breakdown.
Each Daughter company is taking a revolutionary approach to tackling one or more of the causes of aging, with a mission of making the solutions affordable and accessible to all.
Learn MorePepsiCo’s Former Vice Chairman and Chief Scientific Officer, Former President of Global R&D, Takeda Pharmaceuticals, to Lead Longevity Biotech BOSTON, MARCH 4 – Life Biosciences Inc. today announced Dr. Mehmood Khan, former PepsiCo Vice Chairman and Chief Scientific Officer, is incoming Chief Executive Officer and member of its board of directors. Dr. Khan will lead the … Continued
Read Full ArticleWhat if you could live to 115, and have those be productive, healthy and entirely enjoyable years? Nir Barzilai, M.D., a renowned longevity expert, says it just may be possible. Listen to what he has to say about that, “zombie cells,” and what may be the cause of Alzheimer’s. By Adam Bluestein Nir Barzilai, M.D., … Continued
Read Full ArticleLUA TECHNOLOGIES, A SUBSIDIARY OF LIFE BIOSCIENCES, RATED AS THE LEADING POST-ACUTE SECURE MESSAGING SOLUTION BY KLAS RESEARCH* Top Healthcare Data and Insights Company Uses Impartial Research for Key Industry Reports Used by Providers and Payers Worldwide BOSTON, February 14 –Lua Technologies, a subsidiary of Life Biosciences Inc, has been ranked the highest scoring post-acute secure … Continued
Read Full ArticlePrana Biotechnology Ltd (ASX: PBT, NASDAQ: PRAN) has today announced the US Food and Drug Administration (FDA) has granted Orphan Drug designation for its lead molecule, PBT434, for the treatment of Multiple System Atrophy (MSA). This is the first time the FDA has granted orphan designation to a drug for the treatment of MSA. Orphan Drug … Continued
Read Full Article
